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Abstract: Traumatic brain injury (TBI) may lead to impairments in various outcome domains. Since
most instruments assessing these are only available in a limited number of languages, psychometri-
cally validated translations are important for research and clinical practice. Thus, our aim was to
investigate the psychometric properties of the patient-reported outcome measures (PROM) applied
in the CENTER-TBI study. The study sample comprised individuals who filled in the six-months
assessments (GAD-7, PHQ-9, PCL-5, RPQ, QOLIBRI/-OS, SF-36v2/-12v2). Classical psychometric
characteristics were investigated and compared with those of the original English versions. The
reliability was satisfactory to excellent; the instruments were comparable to each other and to the
original versions. Validity analyses demonstrated medium to high correlations with well-established
measures. The original factor structure was replicated by all the translations, except for the RPQ,
SF-36v2/-12v2 and some language samples for the PCL-5, most probably due to the factor structure
of the original instruments. The translation of one to two items of the PHQ-9, RPQ, PCL-5, and
QOLIBRI in three languages could be improved in the future to enhance scoring and application at
the individual level. Researchers and clinicians now have access to reliable and valid instruments to
improve outcome assessment after TBI in national and international health care.
Keywords: psychometric properties; patient-reported outcome measures; traumatic brain injury;
classical test theory
1. Introduction
Traumatic brain injury (TBI) causes alterations in brain function, as a result of an
external force [1], for example, due to falls, road traffic accidents, sports, assaults, or
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violence. It is a considerable source of disability and death worldwide. The sequelae of TBI
not only impact the lives of those affected and their relatives on many different levels [2],
but they can also result in high direct and indirect costs [3,4].
Concerning the global prevalence of TBI, the vast majority of individuals experience
mild TBI (70–90%), approximately 10% to 30% suffer from moderate or severe TBI [5,6].
Regardless of the severity, individuals after TBI may suffer from short- or long-term im-
pairments in cognition [7,8], psychosocial functioning [9], health-related quality of life
(HRQoL) [10,11], mental health [12,13], and/or functional disability [14]. These impair-
ments can be assessed using domain-specific outcome measures.
The data analyzed in this study were collected in the international Collaborative
European NeuroTrauma Effectiveness Research in TBI observational study (CENTER-TBI;
clinicaltrials.gov NCT02210221), which has been conducted since 2014 in 18 European
countries and Israel, with enrolment being completed at the six-month outcome assessment
in 2018. This study aimed to capture a contemporary picture of TBI with respect to all
severity groups, its care and outcome, to develop precision medicine approaches and apply
comparative effectiveness research to identify best practices. It provides insights into the
longitudinal detection of somatic, functional, behavioral, psychiatric, cognitive, psycholog-
ical, and psychosocial sequelae after TBI and can serve as a basis for the development of a
new multidimensional assessment approach [15,16].
An important criterion when selecting instruments for research and clinical practice
is their psychometric quality. For most patient-reported outcome measures (PROMs)
administered in the CENTER-TBI study this had not yet been examined in the field of
TBI, nor had the newly translated versions of the instruments been psychometrically
investigated. Hence, the present study aims to investigate the classical psychometric
properties of the newly and previously translated PROMs in the field of TBI administered
in the CENTER-TBI study.
In research and clinical contexts, instruments offer insights into outcome after TBI. The
comparability of the translated instruments with their original version and the validation
in the field of TBI enables the reliable and valid aggregation of data in multi-center national
and international studies on outcomes after TBI.
The study aims are the investigation of:
1. The reliability (total score, scale, and item level) of the PROMs, comparing them with
the values of the original instrument versions to ascertain the quality and comparabil-
ity of the translations and applicability in the field of TBI;
2. The convergent and discriminant validity of the PROMs with established measures
assessing functional recovery after TBI (GOSE), generic HRQoL (SF-36v2/SF-12v2),
and TBI severity (GCS);
3. The factorial validity using confirmatory factor analyses (CFA) to replicate the original
factorial structure of the translated instruments.
2. Materials and Methods
2.1. Participants
Participants were recruited at 63 centers across 18 countries, from 19 December 2014
to 17 December 2017. Ethical approval was secured for each site and informed consent was
obtained from all patients or from their legal representatives. The inclusion criteria for the
core study were a clinical diagnosis of TBI, presentation within 24 h after injury, and an
indication for a computed tomography (CT) scan. Patients were differentiated into three
strata: emergency room (ER; patients primarily evaluated at an ER), admission (ADM;
patients admitted primarily to a hospital ward), and intensive care unit (ICU; patients
who were primarily admitted to an ICU). Further details can be found elsewhere [16].
Data were retrieved from the core 2.1 of the CENTER-TBI database using the data access
tool Neurobot.
The core study sample included 4509 individuals. In the present study, we focused on
participants aged 16 years and above who had completed at least one outcome measure
J. Clin. Med. 2021, 10, 2396 3 of 34
at the six months’ assessment after the TBI. The data were collected either on-site at the
hospital by personnel, by face-to-face or telephone interviews (clinical ratings), or via mail
(PROMs) and centrally entered using a web-based electronic case report form.
2.2. Sample Charachteristics
Language, sex, age, education, employment, marital status, and living situation were
selected as sociodemographic characteristics. Samples were then aggregated by language.
More specifically, individuals from German-speaking communities in Austria, Belgium,
and Germany were integrated into the German sample, individuals from French-speaking
communities in Belgium and France into the French sample, and individuals from Dutch-
speaking communities in Belgium or the Netherlands were merged into the Dutch sample.
Only few participants (N = 20) received the outcome questionnaires in a language other
than in the local language of the participating site. These individuals were classified
according to their respective language group: Dutch (7), English (8), German (1), Romanian
(3), and Swedish (1).
The following variables were used to characterize extracranial and brain injuries:
the individuals’ mental health status before the injury, clinical care pathways, cause of
injury, loss of consciousness (LOC), post-traumatic amnesia (PTA), TBI severity (GCS),
abnormalities on computed tomography (CT) scans, total injury severity score (ISS), and
brain injury severity score from the Abbreviated Injury Scale (AIS) [17].
2.3. Pataient-Reported Outcome Measures (PROMs)
Since most instruments applied in the CENTER-TBI study only existed in English,
they had to be translated into the languages of the participating countries following a
formalized approach (i.e., linguistic validation) to ensure their linguistic, cultural and
conceptual comparability in the respective languages [18,19]. For more details, see von
Steinbuechel et al. [20].
The selection of the outcome measures was informed by the Common Data Elements
(CDE) recommendations [21,22]. For six out of eight PROMs (see instrument description
marked with an asterisk * below), at least one translation had to be performed. In this
study, we report psychometrics for all eight PROMs newly and previously translated yet
not validated instruments in the field of TBI.
The Generalized Anxiety Disorder 7 Item Scale (GAD-7)* [23] measures the level of
generalized anxiety disorder using seven items and a four-point Likert scale (from 0 “not
at all” to 3 “nearly every day”). The total score ranges from 0 to 21 with values of 10 and
above indicating impairment and cut-offs of 5, 10, and 15 representing mild, moderate, and
moderately severe to severe anxiety, respectively [23].
The Patient Health Questionnaire (PHQ-9)* [24] assesses self-reported symptoms of
major depression using nine items and a four-point Likert scale (from 0 “not at all” to 3
“nearly every day”). The PHQ-9 total score ranges from 0 to 27 with a score of 10 and above
indicating clinically relevant impairment and cut-offs of 5, 10, 15, and 20 indicating mild,
moderate, moderately severe, and severe depression, respectively [24,25].
Both the GAD-7 and PHQ-9 were available in almost all languages except for Latvian
(GAD-7 and PHQ-9) and Serbian (GAD-7 only). Nevertheless, we conducted analyses on
both instruments to examine their psychometric properties in individuals after TBI.
The Posttraumatic Stress Disorder Checklist-5 (PCL-5)* [26] comprises 20 symptoms
of post-traumatic stress disorder (PTSD) based on the Diagnostic and Statistical Manual
of Mental Disorders, 5th edition (DSM-5) [27], using a five-point Likert scale (from 0
“not at all” to 4 “extremely”). The total score ranges from 0 to 80 with higher values
indicating greater impairment. For clinical screening, either a cut-off score of 31 [28] or 33
is applied [29].
The Rivermead Post-Concussion Symptoms Questionnaire (RPQ)* [30] uses a five-
point Likert scale (from 0 “not experienced at all” to 4 “a severe problem”) to evaluate the
following 16 post-concussion symptoms: headaches, dizziness, nausea and/or vomiting,
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noise sensitivity, sleep disturbance, fatigue, irritability, depression, frustration, forgetfulness
and poor memory, poor concentration, slow thinking, blurred vision, light sensitivity,
double vision, and restlessness. Participants rate how much they have been suffering from
these symptoms during the past 24 h compared with their condition before the accident.
The RPQ total score ranges from 0 to 64 with cut-offs of 13, 25, and 33 indicating mild,
moderate, and severe symptoms, respectively [31].
The Quality of Life after Brain Injury Scale (QOLIBRI)* [32,33] measures TBI-specific
HRQoL in individuals after TBI. It consists of six domains comprising 37 items using a five-
point Likert scale (from 0 “not at all” to 4 “very”). The six domains comprise cognition, self,
daily life and autonomy, social relationships, emotions, and physical conditions. The total
score is transformed linearly to range from 0–100, whereby higher values indicate better TBI-
specific HRQoL [34]. Patients after TBI with a score below 60 may be assumed to display
impaired HRQoL [34]; country-specific reference values can be found elsewhere [35]. For
the QOLIBRI, psychometric criteria of almost all target language versions involved in
the present study (except for Swedish) had already been published [32,36]. The Spanish
translation was published after CENTER-TBI had started [37]. To be congruent with the
analyses of other PROMs, we replicated the psychometric analyses for the nine language
versions of the QOLIBRI.
The Quality of Life after Brain Injury—Overall Scale (QOLIBRI-OS)* [38] is the short
version of the QOLIBRI measuring the physical condition, cognition, emotions, daily
life and autonomy, social relationships, and current and future prospects with using six
items. The items are answered on a five-point Likert scale (from 0 “not at all” to 4 “very”).
Patients after TBI with a score below 52 may be assumed to display impaired HRQoL [34];
country-specific reference values can be found elsewhere [39]. For the QOLIBRI-OS too,
psychometric properties have already been examined in almost all languages, except for
Spanish and Swedish [38]. Here, again, psychometric analyses were replicated in all
languages to be congruent with the other PROMs.
The 36-item Short Form Health Survey—Version 2 (SF-36v2) [40,41]. The SF-36v2
measures subjective health status using 36 items with various response formats for each
of the eight scales (from dichotomous “yes/no” to polytomous five-point Likert scale
responses). The scales can be summed to produce the physical component score (PCS) and
mental component score (MCS) measuring physical and mental functioning, respectively.
Both scores range from 0 to 100 with higher values indicating better HRQoL. The values
can be transformed into T-scores (M = 50, SD = 10) based on a normative U.S. sample. A
value below 47 on a single health domain scale or component summary score is indicative
of functional impairment in comparison to the U.S. population [40].
The 12-Item Short Form Survey—Version 2 (SF-12v2) [42] is a short, 12-item version of
the SF-36v2. The scores range from 0 to 100 with higher values indicating better HRQoL.
The raw values can be transformed into T-scores (M = 50, SD = 10) based on a normative
U.S. sample. However, the authors recommend using country- and group-specific cut-off
values as not every country/group has a mean health of 50 [42,43]. In the CENTER-TBI
study, the SF-12v2 was found to have more missing data than the SF-36v2. Therefore, to
increase the power for the calculation of the PCS and MCS of the SF-12v2, missing values
were replaced by values derived from the respective items of the SF-36v2 and combined
with reported data. For the analyses on the item level, only reported data were used.
The SF-36v2 and SF-12v2 translations were already available in the target languages
and had to be purchased from Optum for one-time use [44]. However, since most translated
versions of both the SF-36v2 and the SF-12v2 were not subjected to psychometric analyses
in the field of TBI, they were included in the analyses of the present study. Both instruments
were also used for validity analyses.
2.4. Clinician-Reported Outcome (ClinRo) and a Clinical Scale
The instruments listed below were used to analyze convergent and discriminant
validity.
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The Glasgow Outcome Scale Extended (GOSE) [45] is a clinician-reported outcome
(ClinRo) of functional recovery after TBI using an eight-point scale (1 = dead, 2 = vegeta-
tive state, 3/4 = lower/upper severe disability, 5/6 = lower/upper moderate disability,
7/8 = lower/upper good recovery) and is based on structured interviews (GOSE) or self-
ratings by individuals after TBI or their proxy (the questionnaire version; GOSE-Q [46]).
Missing GOSE values were centrally replaced by values derived from the GOSE-Q. Since
the GOSE-Q is not able to differentiate between vegetative state and lower severe disability,
GOSE levels 2 and 3 were collapsed into one category. The missing values at six-months
outcome assessments were imputed using a multi-state model; the imputation procedure
is described elsewhere [47]. The GOSE was not subjected to reliability analyses, as it
would require data from independent raters to provide interrater reliability, which was not
available in the CENTER-TBI database.
The Glasgow Coma Scale (GCS) [48] allows healthcare professionals to consistently
evaluate the level of consciousness of individuals after TBI, also classifying the severity of
TBI. The GCS scores range from 3 (no response) to 15 (normal level) with higher values
indicating less impaired consciousness and lower TBI severity. Scores of 13 to 15 indicate
mild TBI, 9 to 12 moderate TBI, and 3 to 8 severe TBI.
2.5. Statistical Analyses
The present study focuses on the analyses of reliability, convergent and discriminant
validity of eight PROMs in nine TBI language samples with enough participants (i.e., at
least 50 participants in the Dutch, English, Finnish, French, German, Italian, Norwegian,
Spanish, and Swedish samples) as well as factorial validity in six samples (i.e., at least
150 participants in the Dutch, English, Finnish, Italian, Norwegian, and Spanish samples).
Figure 1 provides an overview of our psychometric analyses according to the classical test
theoretical (CTT) criteria with the respective cut-off values [49].




Figure 1. Criteria of classical test theoretical psychometric analyses and their application in this study. The white boxes 
indicate analyses performed in this study; the grey boxes describe psychometric properties investigated either during 
instrument development (i.e., content validity), or alternative methods of retest reliability or parallel form reliability, or 
analyses deferred to further studies (i.e., measurement invariance and interpretation). 
2.6. Descriptive Statistics 
Descriptive statistics include information on the sample sizes, percentage of missing 
data, mean (M), standard deviation (SD), skewness (SK), and kurtosis (KU) for each item 
per language version of an instrument and an average of the item characteristics across all 
languages. For skewness, values less than −1 or greater than 1 indicate a highly skewed 
distribution; values from ±1 to ±0.5 show that the distribution is moderately skewed; val-
ues from −0.5 to +0.5 denote a symmetrical distribution. For asymmetry and kurtosis, val-
ues between −2 and +2 are considered acceptable [50]. 
2.7. Reliability 
For reliability analyses, researchers often accept data of 30 participants as being suf-
ficient to detect a required minimal effect of 0.70 as a cut-off value for reliability coeffi-
cients [51]. However, some researchers argue that larger sample sizes are required to 
avoid bias [51,52]. In the present study, reliability coefficients were therefore only calcu-
lated if the sample size comprised at least 50 individuals per language, to provide more 
robust results. 
To examine the reliability of each instrument, Cronbach’s alpha, split-half reliability 
with the Spearman–Brown correction (odd vs. even items), and Cronbach’s alpha if an 
item is omitted were reported. Both, the split-half reliability and the Cronbach’s alpha if 
item omitted were calculated for scales with at least three items. Although different 
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2.6. Descriptive Statistics
Descriptive statistics include information on the sample sizes, percentage of missing
data, mean (M), standard deviation (SD), skewness (SK), and kurtosis (KU) for each item
per language version of an instrument and an average of the item characteristics across all
languages. For skewness, values less than −1 or greater than 1 indicate a highly skewed
distribution; values from ±1 to ±0.5 show that the distribution is moderately skewed;
values from −0.5 to +0.5 denote a symmetrical distribution. For asymmetry and kurtosis,
values between −2 and +2 are considered acceptable [50].
2.7. Reliability
For reliability analyses, researchers often accept data of 30 participants as being
sufficient to detect a required minimal effect of 0.70 as a cut-off value for reliability coeffi-
cients [51]. However, some researchers argue that larger sample sizes are required to avoid
bias [51,52]. In the present study, reliability coefficients were therefore only calculated if the
sample size comprised at least 50 individuals per language, to provide more robust results.
To examine the reliability of each instrument, Cronbach’s alpha, split-half reliability
with the Spearman–Brown correction (odd vs. even items), and Cronbach’s alpha if an
item is omitted were reported. Both, the split-half reliability and the Cronbach’s alpha
if item omitted were calculated for scales with at least three items. Although different
recommendations in terms of cut-off points for the Cronbach’s alpha do exist, there is an
agreement that in group comparisons Cronbach’s alpha should reach at least a value of
0.70 implying acceptable internal consistency [53]; an alpha above 0.90 indicates excellent
internal consistency [54]. The Cronbach’s alpha value, if an item has been omitted, should
not exceed the total Cronbach’s alpha of a scale. A value higher than the total Cronbach’s
alpha indicates that the excluded item decreases the reliability of the instrument and
requires further revision [55].
To evaluate the discriminating ability of the items, item–total correlations either at
the scale or at the total score level, or both were calculated. A correlation coefficient of
0.30, corresponding to a medium effect size, was chosen as the cut-off criterion, based
on the guidelines for effect size proposed by Cohen [56,57]. An item–total correlation
below 0.30 implies that the item cannot discriminate well between high-performing and
low-performing individuals. Furthermore, low item–total correlations, especially at the
scale level, may identify irregularities of the factorial structure of an instrument.
2.8. Validity
2.8.1. Convergent and Discriminant Validity
All language samples analyzed in this study included at least 50 observations, which
is recommended for validity analyses [58].
Spearman correlation coefficients were used to examine associations between the
GOSE, physical (PCS) and the mental component score (MCS) of the SF-36v2 and SF-12v2,
and the total scores/domain-specific scores of all other measures.
Discriminant validity was investigated by calculating Spearman correlation coeffi-
cients for the GCS and the total and scale scores of all instruments, to be in line with
analyses already provided in the field of TBI [59]. To evaluate the strength of correlations,
the Cohen criteria [56,57] were applied to identify small (0.10), medium (0.30), and large
(0.50) effect sizes.
2.8.2. Factorial Validity
Factorial validity was examined by means of confirmatory factor analyses (CFA) and
a robust weighted least squares estimator (WLSME) for ordinal data, whereby only the
original factor structure of the instruments was analyzed. Therefore, one-factor solutions
were estimated for the GAD-7 [23], the PHQ-9 [24], the RPQ [30], and the QOLIBRI-OS [38].
For the other instruments, respective multiple scale models were inspected: a four-factor
model for the PCL-5 [26], a five-factor model for the QOLIBRI [32], an eight-factor model
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with two second-order factors for the SF-36v2 [40], and finally, a two-factor model for
the SF-12v2 [42]. In CFA analyses, samples should comprise at least 150 observations
to provide stable results [60]. Therefore, only language samples fulfilling this criterion
were analyzed.
The model fit was evaluated based on the following fit indices using the respective cut-
off values (in paratheses): χ2 statistics with respective p-values (p > 0.01) [61], comparative
fit index (CFI > 0.95) [62], Tucker–Lewis index (TLI > 0.95 [63]) root mean square error
of approximation (RMSEA < 0.06) [64] with a 90-percent confidence interval (CI), and
standardized root mean square residual (SRMR < 0.08) [63]. As some of the fit indices
may be biased (e.g., χ2 test can be influenced by large sample size [61]), all indices were
considered simultaneously to evaluate the model fit. Furthermore, item loadings over 0.50
were considered acceptable and over 0.70 desirable [53].
Analyses were performed using the packages psych [65] for psychometric characteris-
tics and lavaan [66] for the factorial validity analyses applying the R version 4.0.2 [67].
2.9. Comparability of the Translated Versions
To evaluate the quality of the translated versions of the eight PROMs, psychometric
criteria obtained from the CENTER-TBI language samples were compared with those
reported for the original English instrument versions. For this purpose, a systematic
literature search was carried out. Psychometric characteristics were compared with those
obtained from the original validation studies in the original populations, for which the
respective instrument was developed. If available, they were also compared with the
validation studies in the field of TBI. If the original articles did not provide information on
all coefficients, these were retrieved from more recent studies.
These comparisons were confined to the reliability coefficients (i.e., Cronbach’s alpha
coefficients, split-half or test–retest reliability), as validity testing in the original studies
was performed using instruments not applied in the CENTER-TBI study. Instruments
showing reliability within the same ranges (i.e., <0.70—acceptable, 0.70–0.89—good, ≥0.90—




For the CENTER-TBI study, eight PROMs were translated or already available in
20 target languages (Figure 2). As some countries withdrew from the project early (Bulgar-
ian and Czech centers) or no participants were recruited (Arabic and Russian), 16 countries
participated in the study. Seven out of 16 language samples (i.e., Danish, Hungarian,
Hebrew, Lithuanian, Latvian, Romanian, and Serbian) were not psychometrically analyzed
due to a low number of observations (N < 50). Additionally, three language samples
(French, Norwegian, Swedish) had to be excluded from the reliability analyses of the
SF-12v2, also because of insufficient sample sizes. For the factorial validity, six language
samples comprising at least N = 150 observations (i.e., Dutch, English, Finnish, Italian,
Norwegian, and Spanish) were investigated for all instruments except for the SF-12v2, as
only three SF-12v2 language samples (i.e., Dutch, Finnish, and Spanish) fulfilled the sample
size criteria.
The number of participants varied between PROMs, since not every participant filled
in each instrument at the six-months outcome assessment. Sample characteristics for
each instrument and language are provided in the Online Supplement (OS 1: Sample
characteristics, Tables S1–S8). A brief overview on the sample compositions used for the
analyses is presented in Figure 2. Appendix A (Table A1) provides additional information
on the number of participants for the validity analyses using the GOSE and the GCS.
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3.2. Reliability and Comparability of the PROMs
Reliability coefficients for the total and scale scores of the PROMs are shown below.
Item characteristics as well as reliability coefficients on the item level are reported in the
respective tables in the Online Supplement 2 (OS-2 Reliability, Tables S1–S8).
3.2.1. GAD-7
All translations analyzed were available prior to the CENTER-TBI study. Item scores
for the GAD-7 were not normally distributed (SK: M = 1.64, SD = 0.51; KU: M = 2.40,
SD = 2.22) across all languages. At the item level, most items were moderately to strongly
correlated with the total score of the GAD-7 in most languages (0.36 to 0.89). When calcu-
lating Cronbach’s alpha if item omitted, all values were smaller than the total Cronbach’s
alpha across all languages. The values of the split-half reliability ranged from 0.70 to 0.90
across all languages. On the total score level, all translations revealed Cronbach’s alpha
and split-half reliability values comparable to the results of the original English versions in
a non-TBI population (i.e., patients from 15 primary care sites [23]) except for the Finnish,
German, Spanish, and Swedish versions showing Cronbach’s alpha values slightly lower
than 0.90, but over 0.80. The reliability results were within the same or higher range (0.70
to 0.89 and ≥0.90) compared to the validation in an English TBI sample [68] (see Table 1).
Table 1. Reliability of the GAD-7: Comparison of the CENTER-TBI results with the values from the original English
validation study and the first English validation study in the field of TBI.
GAD-7
CENTER-TBI 1 Original English Version 2
Dutch English Finnish French German Italian Norwegian Spanish Swedish Non-TBI TBI
N 584 214 207 109 78 266 253 253 60 2740 1838
Cronbach’s alpha 0.92 0.90 0.86 0.94 0.84 0.92 0.90 0.89 0.86 0.92 0.88




0.93 0.91 0.89 0.95 0.85 0.95 0.93 0.93 0.83 0.83 -
Note. 1 Reliability coefficients obtained from the CENTER-TBI study sample. 2 Reliability coefficients from the original English validation
of the GAD-7 in a non-TBI sample [23], and from the first English validation in a TBI sample [68]. 3 Split-half reliability (CENTER-TBI data),
test–retest reliability provided by original studies; N = number of cases; values in bold represent at least satisfactory reliability (≥0.70).
3.2.2. PHQ-9
All analyzed PHQ-9 translations were available prior to the CENTER-TBI study. The
items of the PHQ-9 were not normally distributed (SK: M = 1.66, SD = 0.80; KU: M = 2.71,
SD = 3.85) across all languages. At the item level, all items were moderately to highly
correlated with the total scores of the PHQ-9 across all languages, except for Swedish.
Here, the item “Moving or speaking so slowly that other people could have noticed” had a low
correlation (r = 0.18) with the total score. At the total score level, the Cronbach’s alpha
values were above 0.70 (0.78 to 0.89) in every language. When calculating Cronbach’s alpha
if item omitted, no value exceeded the total Cronbach’s alpha. The values of the split-half
reliability ranged from 0.85 to 0.90. Reliability coefficients were comparable (i.e., ranged
from 0.70 to 0.89 and above) with those obtained from the original English publication in a
non-TBI population (i.e., primary care patients from five general health clinics and three
family practice clinics) [24]. The Cronbach’s alpha coefficients calculated from CENTER-
TBI data were slightly lower compared with the results from the first English validation
study in a TBI sample [69], whereas the results of the split-half reliability were within a
comparable range [70] (see Table 2).
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Table 2. Reliability of the PHQ-9: Comparison of the CENTER-TBI results with the values from the original English
validation study and the first English validation study in the field of TBI.
PHQ-9 CENTER-TBI
1 Original English Version 2
Dutch English Finnish French German Italian Norwegian Spanish Swedish Non-TBI TBI
N 587 214 206 107 81 265 254 253 60 3000 168 †
Cronbach’s alpha 0.88 0.88 0.86 0.87 0.85 0.89 0.89 0.88 0.78 0.89 0.91 †




0.90 0.90 0.92 0.91 0.90 0.91 0.91 0.91 0.85 0.84 0.76 ‡
Note. 1 Reliability coefficients (CENTER-TBI study sample). 2 Reliability coefficients (original English validation of the PHQ-9 in a non-TBI
sample [24] and from two English validations in TBI samples) † Cronbach’s alpha [69] and ‡ test–retest reliability [70]. 3 Split-half reliability
(CENTER-TBI data), test–retest reliability provided by original studies; N = number of cases; values in bold represent at least satisfactory
reliability (≥0.70).
3.2.3. PCL-5
All but the Norwegian version of the PCL-5 were translated for the CENTER-TBI study.
The items of the PCL-5 were not normally distributed (SK: M = 1.75, SD = 0.66; KU: M =
2.70, SD = 2.99) across all languages. At the scale (i.e., DSM-5 cluster) level, most items had
medium to high correlations with the cluster total scores of the PCL-5 across all languages.
Only the item “Trouble remembering important parts of the stressful experience” displayed
borderline correlations with the total cluster scores in French (r = 0.20), Norwegian (r =
0.28), and Swedish (r = 0.28) language samples. The internal consistency was satisfactory to
excellent (0.74 to 0.92) at the cluster level. All split-half reliability coefficients demonstrated
at least satisfactory reliability (i.e., ≥0.70). At the total score level, the values of the
Cronbach’s alphas ranged from 0.91 to 0.94 in all languages. The Cronbach’s alphas if
item omitted did not exceed the values of the initial Cronbach’s alpha except for the item
“Trouble remembering important parts of the stressful experience” in all but English and German
language samples. The split-half reliability was excellent (0.92 to 0.96) across all languages.
Cronbach’s alpha coefficients on the total score and the cluster level were comparable to
the original English validation results in a non-TBI sample (i.e., undergraduate students
having experienced a stressful life event [26] and military service members [71]) in all
translations. No publications on psychometric properties of the PCL-5 in the field of TBI
samples were found (see Table 3).
Table 3. Reliability of the PCL-5: Comparison of the CENTER-TBI results with the values from the original English
validation study.
PCL-5 DSM-5Cluster
CENTER-TBI 1 Original English Version 2
Dutch * English Finnish * French * German * Italian * Norwegian Spanish * Swedish * Non-TBI TBI
N - 586 213 212 110 76 261 248 256 57 278 † -
Cronbach’s
alpha
B 0.90 0.89 0.81 0.89 0.88 0.90 0.90 0.88 0.88 0.80
-
C 0.79 0.83 0.78 0.92 0.77 0.90 0.82 0.82 0.82 0.83
D 0.85 0.84 0.79 0.83 0.78 0.83 0.79 0.87 0.80 0.82
E 0.79 0.81 0.83 0.83 0.74 0.83 0.82 0.84 0.76 0.75
Total 0.93 0.94 0.92 0.93 0.92 0.95 0.93 0.94 0.91 0.94 † /0.92




B 0.92 0.91 0.86 0.91 0.91 0.92 0.92 0.88 0.84 0.80
-
C - - - - - - - - - 0.83
D 0.87 0.87 0.83 0.84 0.86 0.85 0.83 0.89 0.85 0.82
E 0.84 0.85 0.84 0.85 0.78 0.85 0.86 0.90 0.88 0.75
Total 0.96 0.95 0.94 0.94 0.92 0.95 0.95 0.96 0.92 0.82 † /0.91
Note. * Instruments translated and linguistically validated for the CENTER-TBI study. 1 Reliability coefficients (CENTER-TBI study sample).
2 Reliability coefficients (original English validation of the PCL-5 in a non-TBI sample on the † total score level [26]) and on the total score
and cluster level [71]. 3 Split-half reliability (CENTER-TBI data), test–retest reliability provided by original studies; DSM-5 clusters: B =
Intrusion; C = Avoidance; D = Negative alterations in cognition and mood; E = Hyperarousal; Cronbach’s alpha and split-half reliability not
reported due to the scale length (two items); N = number of cases; values in bold represent at least satisfactory reliability (≥0.70).
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3.2.4. RPQ
All but the German and Norwegian versions of the RPQ were translated for the
CENTER-TBI study. The item score distributions of the RPQ were skewed (SK: M = 1.31,
SD = 0.83; KU: M = 1.37, SD = 4.07) across all languages. At the item level, most items
displayed medium to high correlations with the total scores of the RPQ. In the German
translation, the item “Double Vision” had a borderline correlation with the total score of
the RPQ (r = 0.25). The item “Nausea” of the German and Swedish translations displayed
rather low correlations (r = 0.25 and r = 0.24, respectively) with the total score.
At the scale level, however, the values of the Cronbach’s alpha and the split-half
reliability were above 0.70 across all languages. No comparisons between the original
and the translated language versions can be provided for the internal consistency, as
no information was available concerning Cronbach’s alpha in the English RPQ version
investigated in a TBI sample. Moreover, further studies on the RPQ [31,72,73] provided
no information on the internal consistency, as they focused on the factorial structure of
the questionnaire. The test–retest reliability scores in the original study were comparable
to the split-half reliability results of the English and Finnish language samples from the
CENTER-TBI study. The split-half reliability of all other translations was slightly above
0.90 except for the Swedish version (αCronbach = 0.82). For details, see Table 4.
Table 4. Reliability of the RPQ: Comparison of the CENTER-TBI results with the values from the original English validation






Dutch * English Finnish * French * German Italian * Norwegian Spanish * Swedish * TBI
N 597 223 213 115 80 268 263 254 59 41
Cronbach’s alpha 0.93 0.92 0.92 0.92 0.89 0.91 0.92 0.92 0.89 -




0.94 0.95 0.95 0.94 0.93 0.94 0.93 0.92 0.82 0.90
Note. * Instruments translated and linguistically validated for the CENTER-TBI study. 1 Reliability coefficients (CENTER-TBI study
sample). 2 Reliability coefficients from the original English validation of the RPQ in a TBI sample [30]. 3 Split-half reliability (CENTER-TBI
data), test–retest reliability (original validation study); N = number of cases; values in bold represent at least satisfactory reliability (≥0.70).
3.2.5. QOLIBRI
At the total score level, Cronbach’s alpha and the split-half reliability coefficients of all
translated QOLIBRI versions were above 0.90. Item–total correlations displayed medium
to high correlations with the total score except for the German version. Here, the item
“How bothered are you by feeling angry or aggressive” revealed a low correlation with the total
score (r = 0.25). Below, item distributions and reliabilities are reported for each subscale.
Cognition. The items were almost normally distributed (SK: M = −0.91, SD = 0.34;
KU: M = 0.46, SD = 0.78) across all languages and highly correlated with the total score
of the Cognition scale across all languages (0.62 to 0.84). At the scale level, all reliability
coefficients were excellent (Cronbach’s alpha: 0.91 to 0.93; split-half-reliability: 0.90 to 0.94).
Self. The items were approximately normally distributed (SK: M = −0.68, SD = 0.27;
KU: M = −0.11, SD = 0.65) in all languages and correlated highly with the scale score (0.64
to 0.88). Reliability coefficients were excellent (Cronbach’s alpha: 0.92 to 0.94; split-half
reliability: 0.92 to 0.96).
Daily Life and Autonomy. Across all languages, items were nearly normally distributed
(SK: M = −0.97, SD = 0.36; KU: M = 0.18, SD = 0.91). Items correlated highly with the scale
scores (0.61 to 0.86). Reliability coefficients were excellent (Cronbach’s alpha: 0.90 to 0.94;
split-half reliability: 0.92 to 0.96).
Social Relationships. In general, item scores were normally distributed (SK: M = −1.02,
SD = 0.40; KU: M = 0.61, SD = 1.25) across all languages. Correlations for item and scale
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scores ranged from 0.39 to 0.80. Reliability results were satisfactory to excellent for all
translated versions (Cronbach’s alpha: 0.76 to 0.89; split-half reliability: 0.86 to 0.95).
Emotions. On average, the items were nearly normally distributed (SK: M = −1.01,
SD = 0.48; KU: M = 0.25, SD = 1.20) for all languages. All items were moderately to highly
correlated with the total scores of the scale across all languages (0.52 to 0.82). At the scale
level, reliability results were good to excellent (Cronbach’s alpha: 0.82 to 0.89; split-half
reliability: 0.86 to 0.90).
Physical. The item distributions were close to a normal distribution (SK: M = −0.89,
SD = 0.38; KU: M = −0.23, SD = 0.88) across all languages. All coefficients were satisfactory
to good across all languages on the item (item–total correlation: 0.35 to 0.74) as well as on
the scale level (Cronbach’s alpha: 0.76 to 0.88; split-half reliability: 0.76 to 0.88).
All reliability coefficients were comparable (i.e., within the same or higher range)
to those reported in the original publication on a TBI population. As the QOLIBRI was
developed for use in the TBI field, no validation studies in non-TBI populations are reported
(see Table 5).
Table 5. Reliability of the QOLIBRI: Comparison of the CENTER-TBI results with the values from the original English






Dutch English Finnish French German Italian Norwegian Spanish Swedish TBI
N - 583 224 207 104 77 271 247 255 57 97
Cronbach’s
alpha
Cognition 0.92 0.92 0.92 0.93 0.91 0.93 0.93 0.92 0.92 0.92
Self 0.92 0.92 0.94 0.94 0.92 0.94 0.93 0.93 0.92 0.90
Daily life 0.93 0.93 0.92 0.93 0.93 0.94 0.90 0.94 0.92 0.93
Social 0.86 0.88 0.85 0.89 0.87 0.88 0.84 0.84 0.76 0.88
Emotions 0.87 0.85 0.82 0.89 0.86 0.86 0.85 0.86 0.86 0.88
Physical 0.79 0.79 0.79 0.81 0.76 0.85 0.82 0.84 0.75 0.80
Total 0.96 0.96 0.96 0.97 0.96 0.97 0.96 0.96 0.95 0.97






Cognition 0.90 0.91 0.93 0.94 0.92 0.94 0.92 0.91 0.92 0.80
Self 0.93 0.94 0.96 0.95 0.92 0.95 0.94 0.94 0.93 0.83
Daily life 0.95 0.95 0.94 0.94 0.95 0.94 0.92 0.95 0.96 0.77
Social 0.88 0.91 0.86 0.95 0.90 0.89 0.86 0.89 0.86 0.79
Emotions 0.89 0.86 0.87 0.90 0.89 0.88 0.88 0.89 0.88 0.76
Physical 0.78 0.76 0.78 0.80 0.83 0.88 0.83 0.86 0.77 0.83
Total 0.97 0.98 0.98 0.98 0.98 0.98 0.98 0.97 0.98 0.88
Note. 1 Reliability coefficients (CENTER-TBI study sample). 2 Reliability coefficients (original English validation of the QOLIBRI in a
TBI sample [32]). 3 Split-half reliability (CENTER-TBI data), test–retest reliability (original study); N = number of cases; values in bold
represent at least satisfactory reliability (≥0.70).
3.2.6. QOLIBRI-OS
The items of the QOLIBRI-OS were close to being normally distributed (SK: M = −0.71,
SD = 0.23; KU: M = −0.05, SD = 0.53) and were moderately to highly correlated with the
total scores of the QOLIBRI-OS (0.59 to 0.83) across all languages. At the total score level,
the Cronbach’ alpha values were close to or above 0.90 (0.88 to 0.92), and the split-half
reliability ranged from 0.90 to 0.94. Moreover, the values of the Cronbach’s alpha if item
omitted were smaller than the Cronbach’s alpha in each language. The reliabilities of
the translated versions were in general within the same range as those of the original
ones. The split-half coefficients were greater than the test–retest reliability of the original
QOLIBRI-OS. For details, see Table 6.
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Dutch English Finnish French German Italian Norwegian Spanish Swedish TBI
N 602 239 227 109 84 280 261 265 63 97
Cronbach’s
alpha 0.91 0.90 0.92 0.90 0.88 0.91 0.92 0.90 0.91 0.91




0.92 0.92 0.94 0.94 0.90 0.92 0.92 0.93 0.93 0.69
Note. 1 Reliability coefficients (CENTER-TBI study sample). 2 Reliability coefficients (original English validation of the QOLIBRI-OS in a
TBI sample [38]). 3 Split-half reliability (CENTER-TBI data), test–retest reliability (original study); N = number of cases; values in bold
represent at least satisfactory reliability (≥0.70).
3.2.7. SF-36v2
All SF-36v2 translations were available prior to the CENTER-TBI study. The instru-
ment was investigated on the scale and item level and with respect to the mental (MCS)
and physical (PCS) component score.
Physical Functioning (PF). The items were not normally distributed (SK: M = −1.46,
SD = 0.88; KU: M = 1.65, SD = 3.27) across all languages. Items were moderately to
highly correlated with the scale score across all languages (0.56 to 0.91). At the scale
level, all reliability coefficients showed excellent results (Cronbach’s alpha: 0.92 to 0.95;
split-half-reliability: 0.95 to 0.98).
Role-Physical (RP). The items were almost normally distributed (SK: M = -0.50, SD = 0.35;
KU: M = −0.90, SD = 0.45) across all languages and highly correlated with the scale score
across all languages (0.83 to 0.93). At the scale level, all reliability coefficients were excellent
(Cronbach’s alpha: 0.94 to 0.96; split-half-reliability: 0.94 to 0.97).
Bodily Pain (BP). The items were almost normally distributed (SK: M = −0.65, SD = 0.33;
KU: M = −0.60, SD = 0.59) across all languages and highly correlated with the scale score
across all languages (0.78 to 0.83). At the scale level, all reliability coefficients showed
were good to excellent (Cronbach’s alpha: 0.86 to 0.89). The split-half reliability was not
calculated because of the scale length (two items).
General Health (GH). The items were normally distributed (SK: M = −0.60, SD = 0.53;
KU: M = −0.31, SD = 0.88) across all languages. Items were moderately to highly correlated
with the scale score across all languages (0.37 to 0.78). At the scale level, Cronbach’s
alpha was satisfactory to good (0.73 to 0.84). The split-half reliability of the English,
German, Norwegian, Spanish, and Swedish samples was low to borderline (0.59 to 0.69)
and satisfactory for the other languages (0.70 to 0.78).
Vitality (VT). The items were normally distributed (SK: M = −0.28, SD = 0.25; KU:
M = −0.50, SD = 0.37) across all languages and moderately to highly correlated with the
scale score across all languages (0.48 to 0.78). At the scale level, all reliability coefficients
were good to excellent (Cronbach’s alpha: 0.83 to 0.88; split-half reliability: 0.85 to 0.95).
Social Functioning (SF). The items were normally distributed (SK: M = −0.89, SD = 0.34;
KU: M = −0.12, SD = 0.83) across all languages. The items were highly correlated with the
scale score across all languages (0.69 to 0.81). Cronbach’s alpha was good to excellent (0.81
to 0.90); split-half reliability was not calculated because of the scale length (two items).
Role Emotional (RE). Across all languages, items were nearly normally distributed (SK:
M = −1.00, SD = 0.40; KU: M = 0.09, SD = 0.91) in all language samples. They were highly
correlated with the scale score across all languages (0.72 to 0.92). At the scale level, all
reliability coefficients were excellent (Cronbach’s alpha: 0.90 to 0.95; split-half reliability:
0.91 to 0.96).
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Mental Health (MH). The items were close to being normally distributed (SK: M = −0.80,
SD = 0.45; KU: M = 0.22, SD = 1.11) across all languages. They were moderately to highly
correlated with the scale score across all languages (0.48 to 0.83). At the scale level, all
reliability coefficients were good to excellent (Cronbach’s alpha: 0.83 to 0.89; split-half
reliability: 0.81 to 0.92).
The internal consistency of the translated versions of the SF-36v2 was comparable to
the original English version, which was validated in a U.S. general population [40,41]. The
Cronbach’s alpha coefficients on the scale levels were within the same ranges or above.
The split-half reliability coefficients were within the same or higher ranges compared to the
original version. Despite the wide application of the SF-36v2, no studies on psychometric
properties of the English version in the field of TBI for the English version were found.
Physical Component Score (PCS). Items were moderately to highly correlated with the
PCS (0.35 to 0.87) except for the item “I expect my health to get worse” in the English version
(r = 0.23). Cronbach’s alpha ranged from 0.32 to 0.95 and the split-half reliability coefficients
from 0.93 to 0.95. When omitting an item, the newly calculated Cronbach’s alpha did not
exceed the initial value in any language sample. The reliability coefficients were within the
same or higher range compared with the psychometric properties of the original SF-36v2.
Mental Component Score (MCS). The items were moderately to highly correlated with
the MCS (0.43 to 0.88). Cronbach’s alpha (0.92 to 0.95) and split-half coefficients (0.95 to
0.98) indicted a high reliability. When omitting an item, the newly calculated Cronbach’s
alpha values did not exceed the initial one. Here, again, the reliability of the instrument
translations was comparable (i.e., was within the same or higher range) with the results
obtained from the original validation study (see Table 7).
Table 7. Reliability of the SF-36v2: Comparison of the CENTER-TBI results with the values from the original English
validation study.
SF-36v2 Scale
CENTER-TBI 1 Original EnglishVersion 2
Dutch English Finnish French German Italian Norwegian Spanish Swedish Non-TBI TBI
N - 579 220 214 110 78 270 254 255 57 4024–4036 -
Cronbach’s
alpha
PF 0.94 0.94 0.93 0.94 0.92 0.95 0.93 0.94 0.95 0.94
-
RP 0.95 0.95 0.94 0.95 0.95 0.96 0.96 0.96 0.95 0.96
BP 0.89 0.87 0.88 0.88 0.89 0.88 0.87 0.87 0.86 0.87
GH 0.81 0.81 0.84 0.84 0.77 0.81 0.79 0.79 0.73 0.82
VT 0.83 0.87 0.88 0.85 0.85 0.86 0.86 0.83 0.88 0.87
SF 0.82 0.87 0.87 0.90 0.81 0.82 0.87 0.87 0.88 0.84
RE 0.94 0.90 0.91 0.94 0.92 0.94 0.95 0.94 0.93 0.93
MH 0.87 0.83 0.87 0.89 0.85 0.87 0.85 0.86 0.89 0.87
HT - - - - - - - - - -
PCS 0.94 0.94 0.94 0.94 0.93 0.95 0.93 0.95 0.94 0.96
MCS 0.94 0.93 0.94 0.95 0.94 0.94 0.94 0.94 0.94 0.93





PF 0.97 0.97 0.97 0.97 0.95 0.98 0.96 0.97 0.97 0.85
-
RP 0.96 0.94 0.95 0.95 0.97 0.97 0.97 0.97 0.97 0.78
BP - - - - - - - - - 0.71
GH 0.72 0.69 0.78 0.75 0.65 0.74 0.68 0.67 0.59 0.87
VT 0.85 0.90 0.94 0.95 0.89 0.89 0.89 0.91 0.92 0.75
SF - - - - - - - - - 0.70
RE 0.95 0.93 0.91 0.96 0.95 0.95 0.95 0.93 0.93 0.61
MH 0.86 0.82 0.86 0.84 0.86 0.85 0.81 0.83 0.92 0.76
HT - - - - - - - - - -
PCS 0.96 0.96 0.97 0.97 0.94 0.97 0.95 0.97 0.96 0.88
MCS 0.96 0.95 0.96 0.97 0.97 0.97 0.96 0.95 0.98 0.79
Note. 1 Reliability coefficients (CENTER-TBI study sample). 2 Reliability coefficients (original English validation of the QOLIBRI in a
non-TBI sample [41]). 3 Split-half reliability (CENTER-TBI data), test–retest reliability (original validation study); Cronbach’s alpha and
split-half reliability are not reported due to the scale length (two items); PF = Physical functioning; BP = Bodily Pain; GH = General Health;
VT = Vitality; SF = Social Functioning; RE = Role-Emotional; MH = Mental Health; HT = Reported Health Transition; PCS = Physical
Component Score; MCS = Mental Component Score; split-half reliability not reported for the BP and SF scales due to the scale length
(two items); no psychometric properties reported for the HT scale due to the scale length (one item); N = number of cases; values in bold
represent at least satisfactory reliability (≥0.70).
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3.2.8. SF-12v2
All SF-12v2 translations were available prior to the CENTER-TBI study. Many of the
scales of the SF-12v2 consist of two items (PF, RP, RE, MH), and some include one item (BP,
VT, SF, GH); therefore, the reliability coefficients are provided on the physical (PCS) and
mental (MCS) component score level.
Physical Component Score (PCS). The items were close to being normally distributed
(SK: M = −0.54, SD = 0.47; KU: M = −0.64, SD = 0.55) across all languages. On the item
level, all items correlated moderately to highly with the PCS (0.55 to 0.89). At the scale
level, all reliability coefficients were good to excellent (Cronbach’s alpha: 0.86 to 0.94;
split-half-reliability: 0.88 to 0.92).
Mental Component Score (MCS). The items were close to being normally distributed
(SK: M = −0.67, SD = 0.35; KU: M = −0.32, SD = 0.49) across all languages and correlated
moderately to highly with the MCS (0.55 to 0.89). At the scale level, all reliability coefficients
were good to excellent (Cronbach’s alpha: 0.86 to 0.94; split-half-reliability: 0.88 to 0.92).
The reliability of the translated versions of the SF-12v2 was comparable to the original
English version, which was validated in a general U.S. population [42]. The split-half
reliability coefficients (using the CENTER-TBI data) were within the higher range for both
component scores compared with the original version. Despite the wide application of the
SF-12v2, no studies on psychometric properties of the English version in the field of TBI
were found (see Table 8).
Table 8. Reliability of the SF-12v2: Comparison of the CENTER-TBI results with the values from the original English
validation study.
SF-12v2 ComponentScore
CENTER-TBI 1 Original EnglishVersion 2
Dutch English Finnish German Italian Spanish Non-TBI TBI
N - 241 54 172 68 138 210 4002 -
Cronbach’s alpha PCS 0.86 0.91 0.90 0.89 0.89 0.91 0.92 -
MCS 0.89 0.90 0.86 0.94 0.89 0.89 0.88
N - 241 54 172 68 138 210 215 -
Split-half or test–retest
reliability 3
PCS 0.91 0.95 0.92 0.92 0.94 0.95 0.85 -
MCS 0.89 0.90 0.88 0.92 0.89 0.92 0.67
Note. French, Norwegian, and Swedish language samples were excluded from the reliability analyses due to the low number of participants
(N < 50). 1 Reliability coefficients (CENTER-TBI study sample). 2 Reliability coefficients (original English validation of the SF-12v2 in a
non-TBI sample [42]). 3 Split-half reliability (CENTER-TBI study), test–retest reliability (original validation study); N = number of cases;
PCS = Physical Component Score; MCS = Mental Component Score; values in bold represent at least satisfactory reliability (≥0.70).
3.3. Validity
3.3.1. Convergent and Discriminant Validity
Validity coefficients for all PROMs and the PCS and MCS of the SF-36v2 and the
SF-12v2 are provided on the total score level (see Table 9). For details concerning the
validity of the PCL-5, the QOLIBRI, and the SF-36v2 on the scale level, see Appendix B
Tables A2–A4.
Most instruments indicating a degree of impairment (i.e., GAD-7, PHQ-9, PCL-5, and
RPQ) displayed medium to high negative correlations with the PCS of the SF-36v2 (−0.30
to −0.82). Some exceptions were observed in the English (rS = −0.15) and the Swedish
(rS = −0.12) versions of the GAD-7, as well as in the French version (rS = −0.25) of the
PCL-5 which demonstrated low negative correlations. For the instruments measuring
disease-specific HRQoL after TBI (i.e., the QOLIBRI and the QOLIBRI-OS) medium to high
positive correlations with the SF-36v2 PCS domain (0.49 to 0.65) were found across all
languages.
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Table 9. Convergent and discriminant validity of the GAD-7, PHQ-9, PCL-5, RPQ, QOLIBRI, and QOLIBRI-OS with the
SF-36v2, the SF-12v2, the GOSE, and the GCS.
Convergent Validity Discriminant Validity






Dutch −0.31 −0.71 −0.27 −0.70 −0.41 −0.11
English −0.15 −0.76 −0.15 −0.71 −0.36 −0.04
Finnish −0.35 −0.73 −0.34 −0.69 −0.52 −0.20
French −0.33 −0.78 −0.26 −0.74 −0.35 −0.09
German −0.45 −0.74 −0.31 −0.72 −0.24 0.01
Italian −0.31 −0.77 −0.27 −0.74 −0.30 0.06
Norwegian −0.33 −0.74 −0.29 −0.72 −0.32 0.07
Spanish −0.38 −0.72 −0.40 −0.68 −0.39 −0.04
Swedish −0.12 −0.65 −0.22 −0.63 −0.54 −0.30
M −0.30 −0.73 −0.28 −0.70 −0.38 −0.07
Max −0.12 −0.65 −0.15 −0.63 −0.24 0.07
Min −0.45 −0.78 −0.40 −0.74 −0.54 −0.30
SD 0.10 0.04 0.07 0.04 0.10 0.12
PHQ-9
Dutch −0.46 −0.74 −0.43 −0.71 −0.49 −0.14
English −0.33 −0.77 −0.32 −0.74 −0.47 −0.13
Finnish −0.47 −0.77 −0.50 −0.71 −0.56 −0.07
French −0.39 −0.83 −0.36 −0.79 −0.41 −0.19
German −0.60 −0.61 −0.56 −0.68 −0.45 0.06
Italian −0.45 −0.73 −0.43 −0.70 −0.41 −0.01
Norwegian −0.44 −0.76 −0.38 −0.76 −0.37 0.02
Spanish −0.49 −0.76 −0.49 −0.74 −0.44 −0.04
Swedish −0.43 −0.68 −0.52 −0.67 −0.63 −0.33
M −0.45 −0.74 −0.44 −0.72 −0.47 −0.09
Max −0.33 −0.61 −0.32 −0.67 −0.37 0.06
Min −0.60 −0.83 −0.56 −0.79 −0.63 −0.33
SD 0.07 0.06 0.08 0.04 0.08 0.12
PCL-5
Dutch * −0.39 −0.63 −0.36 −0.62 −0.45 −0.20
English −0.29 −0.71 −0.28 −0.66 −0.44 −0.14
Finnish * −0.38 −0.66 −0.40 −0.61 −0.49 −0.20
French * −0.25 −0.69 −0.20 −0.65 −0.31 −0.07
German * −0.44 −0.68 −0.37 −0.62 −0.16 0.17
Italian * −0.35 −0.71 −0.32 −0.67 −0.33 0.07
Norwegian −0.42 −0.66 −0.37 −0.65 −0.42 −0.06
Spanish * −0.32 −0.61 −0.33 −0.55 −0.44 −0.10
Swedish * −0.30 −0.54 −0.37 −0.48 −0.52 −0.24
M −0.35 −0.65 −0.33 −0.61 −0.40 −0.09
Max −0.25 −0.54 −0.20 −0.48 −0.16 0.17
Min −0.44 −0.71 −0.40 −0.67 −0.52 −0.24
SD 0.06 0.05 0.06 0.06 0.11 0.13
RPQ
Dutch * −0.48 −0.64 −0.45 −0.62 −0.54 −0.19
English −0.43 −0.63 −0.47 −0.62 −0.60 −0.26
Finnish * −0.54 −0.60 −0.55 −0.54 −0.63 −0.19
French * −0.44 −0.71 −0.40 −0.67 −0.39 −0.07
German −0.50 −0.44 −0.47 −0.46 −0.52 −0.07
Italian * −0.43 −0.62 −0.44 −0.56 −0.47 −0.07
Norwegian −0.51 −0.59 −0.47 −0.57 −0.58 −0.11
Spanish * −0.52 −0.61 −0.52 −0.56 −0.63 −0.21
Swedish * −0.38 −0.45 −0.44 −0.42 −0.59 −0.34
M −0.47 −0.59 −0.47 −0.56 −0.55 −0.17
Max −0.38 −0.44 −0.40 −0.42 −0.39 −0.07
Min −0.54 −0.71 −0.55 −0.67 −0.63 −0.34
SD 0.05 0.09 0.04 0.08 0.08 0.09
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Table 9. Cont.
Convergent Validity Discriminant Validity






Dutch 0.58 0.71 0.56 0.69 0.54 0.23
English 0.51 0.74 0.53 0.71 0.60 0.21
Finnish 0.59 0.80 0.59 0.72 0.59 0.12
French 0.53 0.76 0.49 0.74 0.53 0.11
German 0.62 0.68 0.56 0.68 0.37 −0.09
Italian 0.55 0.74 0.56 0.71 0.52 0.00
Norwegian 0.53 0.73 0.51 0.71 0.44 −0.01
Spanish 0.65 0.63 0.65 0.61 0.56 0.16
Swedish 0.59 0.66 0.60 0.61 0.64 0.34
M 0.57 0.72 0.56 0.69 0.53 0.12
Max 0.65 0.80 0.65 0.74 0.64 0.34
Min 0.51 0.63 0.49 0.61 0.37 −0.09
SD 0.05 0.05 0.05 0.05 0.08 0.14
QOLIBRI-OS
Dutch 0.58 0.65 0.57 0.66 0.50 0.19
English 0.49 0.72 0.52 0.72 0.53 0.17
Finnish 0.51 0.74 0.55 0.66 0.48 −0.01
French 0.63 0.66 0.60 0.62 0.56 0.25
German 0.63 0.57 0.55 0.67 0.40 −0.08
Italian 0.57 0.65 0.59 0.61 0.44 −0.04
Norwegian 0.49 0.69 0.48 0.66 0.47 0.01
Spanish 0.59 0.58 0.61 0.58 0.55 0.19
Swedish 0.57 0.61 0.59 0.61 0.62 0.40
M 0.56 0.65 0.56 0.64 0.51 0.12
Max 0.63 0.74 0.61 0.72 0.62 0.40
Min 0.49 0.57 0.48 0.58 0.40 −0.08
SD 0.05 0.06 0.04 0.04 0.07 0.16
Note. * Instrument translated and linguistically validated for the CENTER-TBI study; M = mean, Max = maximum, Min = minimum;
SD = standard deviation; SF-36v2-PCS = physical component score; SF-36v2—MCS = mental component score; SF-12v2—PCS = physical
component score SF-12v2—MCS = mental component score.; GCS = Glasgow Coma Scale; GOSE = Glasgow Outcome Scale—Extended.
Values in bold represent an at least medium effect size (≥|0.30|), significant at α = 0.05.
All PROMs indicating a degree of impairment correlated negatively and moderately
to highly with the MCS of the SF-36v2 (−0.44 to −0.83). The ones capturing disease specific
HRQoL displayed medium to high positive correlations (0.57 to 0.80) with the MCS across
all languages.
The PCS of the SF-12v2 was negatively correlated at a low to medium level with
the PHQ-9 (−0.32 to −0.56) and RPQ (−0.40 to −0.55) and positively with the QOLIBRI
(0.49 to 0.65) and the QOLIBRI-OS (0.48 to 0.61) across all languages. The GAD-7 revealed
significant medium correlations with the PCS of the SF-12v2 in Finnish (rS = −0.34), in
German (rS = −0.31), and in Spanish (rS = −0.40); all other values ranged from −0.29 to
−0.15.
All PROMs indicating a degree of impairment were negatively and moderately to
highly correlated with the MCS of the SF-12v2 (−0.42 to −0.79) and positively with the
QOLIBRI and the QOLIBRI-OS (0.58 to 0.74).
Significant medium to high correlations were found between the PROMs and the
GOSE total score, whereby greater impairment was associated with lower functional
recovery status in almost all languages across all instruments (from −0.30 to −0.63). Only
the German version of the GAD-7 (rS = −0.24) and the German version of the PCL-5
(rS = −0.16) demonstrated low associations with the GOSE. Higher TBI-specific HRQoL
was associated with a better functional recovery status across all languages (0.37 to 0.64).
The associations of the PROMs and the GCS were weak and not significant in most lan-
guages. Only the Swedish translations of the GAD-7 (rS = −0.30), the PHQ-9 (rS = −0.33),
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the RPQ (rS = −0.34), the QOLIBRI (rS = 0.34), and the QOLIBRI-OS (rS = 0.40) displayed
medium correlations with the GCS.
3.3.2. Factorial Validity
Table 10 gives an overview on the goodness of fit statistics for the estimated mod-
els. Factor loadings are provided in the Online Supplement (OS-3 Factorial validity,
Tables S1–S8).
Table 10. Factorial validity: results of the CFA.
Instrument Language χ2 df p CFI TLI RMSEA 90% CI SRMR
GAD-7
Dutch 27.90 14 0.015 1.00 1.00 0.04 [0.02,0.06] 0.03
English 38.69 14 <0.001 1.00 0.99 0.09 [0.06,0.13] 0.06
Finnish 15.82 14 0.325 1.00 1.00 0.03 [0.00,0.07] 0.05
Italian 49.29 14 <0.001 1.00 1.00 0.10 [0.07,0.13] 0.05
Norwegian 9.28 14 0.813 1.00 1.00 0.00 [0.00,0.04] 0.03
Spanish 57.87 14 <0.001 0.99 0.99 0.11 [0.08,0.14] 0.06
PHQ-9
Dutch 54.56 27 0.001 1.00 1.00 0.04 [0.03,0.06] 0.05
English 46.62 27 0.011 1.00 0.99 0.06 [0.03,0.09] 0.07
Finnish 54.38 27 0.001 0.99 0.99 0.07 [0.04,0.10] 0.08
Italian 17.65 27 0.914 1.00 1.00 0.00 [0.00,0.02] 0.04
Norwegian 18.63 27 0.883 1.00 1.00 0.00 [0.00,0.02] 0.04
Spanish 42.95 27 0.026 1.00 1.00 0.05 [0.02,0.08] 0.06
PCL-5
Dutch * 264.37 164 <0.001 1.00 1.00 0.03 [0.03,0.04] 0.05
English 241.20 164 <0.001 1.00 1.00 0.05 [0.03,0.06] 0.07
Finnish * NA NA NA NA NA NA NA NA
Italian * 305.80 164 <0.001 1.00 1.00 0.06 [0.05,0.07] 0.07
Norwegian 201.45 164 0.025 1.00 1.00 0.03 [0.01,0.04] 0.06
Spanish * 373.92 164 <0.001 0.99 0.99 0.07 [0.06,0.08] 0.07
RPQ
Dutch * 786.30 104 <0.001 0.99 0.99 0.11 [0.10,0.11] 0.08
English 345.83 104 <0.001 0.99 0.98 0.10 [0.09,0.12] 0.09
Finnish * 280.16 104 <0.001 0.99 0.99 0.09 [0.08,0.10] 0.09
Italian * 429.59 104 <0.001 0.98 0.98 0.11 [0.10,0.12] 0.09
Norwegian 230.42 104 <0.001 0.99 0.99 0.07 [0.06,0.08] 0.08
Spanish * 285.93 104 <0.001 0.98 0.98 0.08 [0.07,0.10] 0.09
QOLIBRI
Dutch 1299.37 614 <0.001 1.00 1.00 0.05 [0.04,0.05] 0.05
English NA NA NA NA NA NA NA NA
Finnish NA NA NA NA NA NA NA NA
Italian 932.84 614 <0.001 1.00 1.00 0.05 [0.04,0.05] 0.05
Norwegian 793.74 614 <0.001 1.00 1.00 0.04 [0.03,0.04] 0.06
Spanish 889.15 614 <0.001 1.00 1.00 0.04 [0.04,0.05] 0.06
QOLIBRI-OS
Dutch 37.15 9 <0.001 1.00 1.00 0.07 [0.05,0.10] 0.03
English 15.22 9 0.085 1.00 1.00 0.05 [0.00,0.10] 0.04
Finnish 11.17 9 0.264 1.00 1.00 0.03 [0.00,0.09] 0.03
Italian 32.07 9 <0.001 1.00 1.00 0.10 [0.06,0.13] 0.04
Norwegian 10.39 9 0.320 1.00 1.00 0.03 [0.00,0.08] 0.02
Spanish 32.14 9 <0.001 1.00 0.99 0.10 [0.06,0.14] 0.04
SF-36v2
Dutch 2552.88 551 <0.001 0.99 0.99 0.08 [0.08,0.08] 0.07
English 1239.59 551 <0.001 0.99 0.99 0.08 [0.07,0.08] 0.09
Finnish NA NA NA NA NA NA NA NA
Italian NA NA NA NA NA NA NA NA
Norwegian 1300.94 551 <0.001 1.00 0.99 0.07 [0.07,0.08] 0.09
Spanish NA NA NA NA NA NA NA NA
SF-12v2
Dutch 295.82 53 <0.001 0.99 0.98 0.14 [0.13,0.16] 0.09
Finnish 162.88 53 <0.001 0.99 0.99 0.11 [0.09,0.13] 0.08
Spanish 113.38 53 <0.001 1.00 1.00 0.07 [0.06,0.09] 0.06
Note. * Instrument translated and linguistically validated for the CENTER-TBI study; χ2 = Chi-square statistic, df = degrees of freedom,
p = p-value, CFI = comparative fit index, TLI = Tucker–Lewis index, RMSEA = root mean square error of approximation; 95% CI = 95%
confidence interval (lower and upper bound); SRMR = standardized root mean square residual; values in bold indicate satisfactory results
according to the respective cut-off values. NA means that the respective model did not converge; no models were estimated for the English,
French, German, Italian, Norwegian, and the Swedish SF12-v2 due to the sample size being too small (N < 150).
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GAD-7. Except for the χ2 statistic and the RMSEA in the Dutch (χ2 only), English,
Italian, and Spanish samples, the fit indices demonstrated that the data fitted the one-factor
model well across the languages. The item loadings were above 0.50 (0.68 to 0.96) indicating
that all items measured a unidimensional construct across the languages.
PHQ-9. Almost all indices exhibited a satisfactory model fit across the languages
except for the χ2 statistic in the Dutch and Finnish translations and RMSEA and SRMR
in the Finnish translation. The item loadings were above 0.50 (0.58 to 0.94) across all
languages. Overall, the one-factor solution was acceptable.
PCL-5. Almost all fit measures exhibited a satisfactory model fit. The χ2 test of all
translations was significant and the RMSEA of the Spanish translation was above the
cut-off value. The model for the Finnish sample did not converge. Average item loadings
on the scale (DSM-cluster) level were above 0.70 (B—Intrusion: 0.84 to 0.91; C—Avoidance:
0.88 to 0.91; D—Negative alterations: 0.75 to 0.81; E—Hyperarousal: 0.73 to 0.79) denoting
an appropriate fit of the four-factor structure of the PCL-5 across all countries. However,
the loadings of the item “Trouble remembering important parts” in the English (0.49) and
Norwegian (0.38) translations were below the cut-off of 0.50.
RPQ. All RPQ translations revealed significant χ2 statistics and the RMSEA and SRMR
values (except for the Dutch and Norwegian versions) were above the respective cut-offs.
The factor loadings varied from 0.41 to 0.92. The item “Headaches” of the Finnish RPQ and
the item “Double Vision” of the Norwegian RPQ reached values below the cut-off. Overall,
the one-factor solution demonstrated a rather poor fit.
QOLIBRI. All but two (the English and Finnish) QOLIBRI translations had satisfactory
fit indices, except for the χ2 statistic, which was significant across all translations. The
English and Finnish models did not converge. The item loadings of the scales were above
0.70 (Cognition: 0.74 to 0.92; Self: 0.75 to 0.93; Daily Life and Autonomy: 0.76 to 0.96; Social:
0.65 to 0.92; Emotions: 0.63 to 0.97; Physical: 0.59 to 0.92). Overall, the original five-factor
structure fitted the data well.
QOLIBRI-OS. For the most part, the CFA results of the QOLIBRI-OS translations
displayed acceptable fit indices, with the RMSEA values of the Dutch, Italian, and Span-
ish translations slightly above the cut-off value and significant χ2 statistics. All other
indices were within acceptable ranges. The factor loadings ranged from 0.73 to 0.92 indi-
cating the unidimensionality of the TBI-specific HRQoL construct across the QOLIBRI-OS
translations.
SF-36v2. Two out of six models did not converge (Finnish and Italian). The CFI and the
TLI of the other translations were satisfactory; nevertheless, χ2 statistics were significant,
and the RMSEA and the SRMR (except for the Dutch translation) were above the respective
cut-off values. All factor loadings on the scale level were above 0.50; one item of the Dutch
version of the SF-36v2 (“Walking several hundred yards”) was exceedingly highly correlated
with the Physical Functioning scale and therefore also with the PCS (r = 1.0). Overall, the
factorial structure of the SF-36v2 with eight scales and two second-order factors did not
show evidence of a good fit.
SF-12v2. The models displayed satisfactory CFI and TLI values across all languages
as well as the SRMR of the Spanish translation. The χ2 statistics were significant and the
RMSEA and SRMR were above permissible cut-off values. The item loadings of the PCS
ranged from 0.69 to 0.97 and of the MCS from 0.67 to 0.95.
4. Discussion
The present study examined psychometric properties of the eight PROMs adminis-
tered in the CENTER-TBI study in individuals after TBI. Many of them were translated
and linguistically validated for this study; others had not yet been psychometrically inves-
tigated in the field of TBI. Therefore, a classical test theorical framework was applied.
The results of the reliability and validity analyses performed on the PROMs indicate
that most newly translated and already existing questionnaires generally displayed satis-
factory to excellent psychometric characteristics in the field of TBI and were comparable to
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each other as well as to the original English versions investigated predominantly in non-TBI
samples, in individuals after TBI, or both. On the scale level, high internal consistency
and scale reliability of the newly translated and already existing instruments across all
languages were observed. On the item level, only very few items from a few questionnaires
demonstrated irregularities, mostly in no more than one language. However, the factorial
validity analyses of the original instruments revealed some difficulties in the replicating
the original factorial structures, indicating a need for further investigations.
Some translations displayed problems at the item level, displaying lower correlations
with the respective total scale scores: the item “Moving or speaking so slowly that other people
could have noticed” from the Swedish PHQ-9, the items “Nausea” in the Swedish and the
German RPQ and “Double Vision” in the German RPQ, and the item “How bothered are
you by feeling angry or aggressive” from the German QOLIBRI. Item–total correlations are
directly related to the factorial structure of a questionnaire; therefore, low correlations may
indicate that the questionnaire does not measure unidimensionally. The QOLIBRI consists
of five scales; thus, the low correlation of the item “How bothered are you by feeling angry or
aggressive” in the German translation is not problematic, as the scale level and total score
level characteristics were satisfactory. Moreover, the low item–total correlations of the
RPQ translations are not unexpected, as the questionnaire underwent several revisions
regarding the scoring by different authors [30,72,73], whereby the items “Nausea” and
“Double Vision” were assigned to different domains. Nevertheless, the low correlation of
the item “Moving or speaking so slowly that other people could have noticed” in the Swedish
PHQ-9 is more difficult to explain, as the PHQ-9 is a unidimensional measure. Problems
with the wording might be a possible explanation, or more likely the composition of the
respective language sample. The Swedish sample contained the most severely impaired
patients (GCS), with the lowest functional level of recovery (GOSE) and the highest injury
severity score (AIS). Thus, individuals in the Swedish sample seem to be more severely
injured compared to other language samples. Therefore, the low correlation of this PHQ-9
item may be attributable to the particularities of the Swedish sample. Future research could
review the wording of this item and examine the Swedish PHQ-9 in a broader spectrum of
TBI severities.
Additionally, one item from the PCL-5 (“Trouble remembering important parts of the
stressful experience”) did not distinguish well between low and high levels of PTSD across
all languages and displayed low correlations with the scale score (i.e., DSM-5 cluster) in
French, Norwegian, and Swedish translations. The factorial structure of the original PCL-5
has been examined on several occasions [74,75], whereby this item was re-assigned to
different dimensions. The results of the present study indicate that PCL-5 translations have
adopted the methodological problem of the original questionnaire version. Thus, further
investigation of the factorial structure of the PCL-5 could lead to an amelioration of the
questionnaire’s psychometric characteristics.
As expected, the validity inspection of the PROMs (newly translated and available
prior to the CENTER-TBI study) indicated medium to strong correlations with the SF-36v2,
the SF-12v2, and the GOSE in most languages. The PCS and MCS of the SF-36v2 and
SF-12v2 generally demonstrated negatively medium to strong negative correlations with
the GAD-7, PHQ-9, PCL-5, and RPQ. One exception was the GAD-7, which revealed a
low correlation with the PCS of the SF-36v2 in English and Swedish and the PCS of the
SF-12v2 in six out of nine languages (Dutch, English, French, Italian, Norwegian, and
Swedish). This might be attributable to the items of the SF-12v2 constituting the PCS
in the original version. While the items of the SF-36v2 cover a wider range of physical
activities and activity-related problems, the items of the SF-12v2 focus on a limited number
of physical problems that are most probably associated less with anxiety. Nevertheless, the
results are generally in line with previous findings suggesting that negative emotions (i.e.,
anxiety, depression, or stress) are highly correlated with generic HRQoL, especially with
the MCS [76,77]. Moreover, the assumption that the mental and physical components of
the SF-36v2 and the SF-12v2 would have strong positive correlations with the QOLIBRI
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and the QOLIBRI-OS was affirmed across all languages, supporting results from previous
studies [34,78].
Generally, the GAD-7 (except for the German language sample), the PHQ-9, the PCL-
5 (except for the German language sample), and the RPQ exhibited medium to strong
negative correlations with the GOSE. The German individuals after TBI had a relatively
high recovery rate with 50% of full recovery after six months (i.e., GOSE = 8); they suffered
a less severe TBI (50% had GCS of 15) and were, consequently, less impaired, as reflected
by the low correlation. These results are in line with previous research showing that the
functional recovery status after TBI is frequently associated with the absence of mental
health problems [79] and post-concussion symptoms [80], and vice versa. The GOSE also
revealed medium to strong positive correlations with the QOLIBRI and QOLIBRI-OS across
all languages, indicating that higher disease-specific HRQoL is associated with better
functional outcomes, which is in line with previous research findings [34,38,81].
Further, the TBI severity as assessed by the GCS rating the degree of consciousness dis-
played a low association with both the psychological and health-related PROMs in almost
all languages except for the Swedish translations of the PHQ-9, the RPQ, the QOLIBRI, and
the QOLIBRI-OS. Previously published validity results in the field of TBI [59] found no as-
sociation between GCS and psychological outcomes and post-concussion symptoms. These
populations contained a lower number of more severely injured individuals, as measured
by the ISS, and therefore, smaller or no correlations were found. In the Swedish transla-
tions, the higher association of the GCS and the outcomes in the Swedish sample might be
explained by the higher injury severity and stronger polytrauma of the participants.
Overall, the original factorial structures suggested by the instrument developers were
replicated for the GAD-7, the PHQ-9, and the QOLIBRI-OS. The translations of the PCL-5
displayed an acceptable model fit, indicating that the initial factorial structure describes
the data well. Nevertheless, we recommend a further investigation of the item “Trouble
remembering important parts of the stressful experience” which displayed irregularities in
both reliability analyses across all languages and the factor loadings of the CFA in some
translations. The five-factor structure of the original QOLIBRI was replicated in all but
two language samples; the English and Finnish models did not converge. This could be
due to several reasons: extreme response categories rarely chosen by the participants,
relatively large number of parameters that must be estimated in relation to the sample size,
or (unconsidered) correlations between latent factors [61].
The original factor solutions could not be replicated for the RPQ translations; this is in
line with previous research findings, as several factor solutions have been proposed for
the RPQ [30,31,72,73]. Since the RPQ has primarily been developed for TBI populations,
further investigation of the factorial structure and thus implementation of an appropriate
scoring are strongly recommended.
The SF-36v2 (except for the Dutch version showing an acceptable model fit) and the SF-
12v2 presented a poor model fit. Neither of these instruments were specifically developed
for populations after TBI, and they use a wide range of different response scales formats,
which might be confusing and tiring, especially for respondents with cognitive deficits, and
affect their response behavior [82] resulting in less good fit of the estimated models [83,84].
For the assessment of generic HRQoL in TBI populations, further investigation of the
factorial structure of both PROMs seems appropriate.
Objectivity. The layout and instructions for administering the newly translated PROMs
were internationally harmonized and are therefore similar across all language versions.
Moreover, instructions for the assessment, scoring, and interpretation were provided (see
the SOPs of the CENTER-TBI study). For the interpretation of results, general population-
based norms or reference values are helpful. For example, for the QOLIBRI, population-
based reference values for the UK and the Netherlands have recently been made avail-
able [35].
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Strengths and limitations of the study. The main strength of the present study is the broad
overview of the psychometric properties of the various previous and newly translated and
linguistically validated PROMs in the TBI field [20], which had not yet been carried out.
The psychometric results allow researchers and clinicians to rate the quality of the
translated questionnaires before selecting them for national and international studies and
clinical practice to evaluate outcomes after TBI.
Because of the small sample sizes in some languages, further modern test theoretical
analyses cannot be reported here. Additional research concerning the assumption of
measurement invariance (MI) across languages could increase the quality of the instruments
even further with respect to the international administration and pooling of international
data. MI analysis evaluates whether the same construct is understood and measured across
different languages. Some of our recent studies have already shown that the PHQ-9 and
GAD-7 [85], QOLIBRI [35], and QOLIBRI-OS [39] applied in the field of TBI measure one
and the same construct across languages. Furthermore, follow-up studies will focus on
assessing measurement invariance comparisons of the different constructs in the individual
PROMs in the different languages and the sensitivity and responsiveness of the PROMs for
different patient groups and risk factors.
The present study also has some limitations. Despite the large number of partici-
pants in the CENTER-TBI core study, the psychometric properties of some translations
could not be examined because of the limited number of participants. Consequently, the
Danish, Hebrew, Hungarian, Latvian, Lithuanian, Romanian, and Serbian translations
of the PROMs need further investigation with a larger number of patients. Furthermore,
given the range of TBI severity (mild to severe) covered, we observed that even six months
after TBI, participants with higher TBI severity with and without extracranial injuries and
polytrauma were not always able to complete the PROMs. To provide robust psychometric
analyses in more severe patient groups, future assessments should be also conducted at
later time points.
5. Conclusions
This study provides psychometric characteristics of the PROMs administered in the
CENTER-TBI study for individuals after TBI. The psychometric properties of these PROMs
are satisfactory to excellent on the scale level in nine European languages. These results
highlight the value of a rigid process of translation and linguistic and cultural adaptation
of questionnaires that goes far beyond a literal translation and that ensures the cultural
comparability of the translated versions. Therefore, researchers and clinicians can now
select reliable and valid instruments for clinical use, data collection, and aggregation, when
evaluating outcomes after TBI in international studies, thus improving outcome assessment
in national and international healthcare.
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GAD-7 Generalized Anxiety Disorder 7 Item Scale
HRQoL Health-related quality of life
PHQ-9 Patient Health Questionnaire
PCL-5 Posttraumatic Stress Disorder Checklist-5
RPQ Rivermead Post-Concussion Symptoms Questionnaire
QOLIBRI Quality of Life after Traumatic Brain Injury
QOLIBRI-OS Quality of Life after Traumatic Brain Injury—Overall Scale
SF-36v2 36-item Short Form Health Survey—Version 2
SF-12v2 12-Item Short Form Survey—Version 2
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Appendix A. Number of Participants (GOSE and GCS)
Table A1. Number of participants for convergent (assessed with the GOSE) and discriminant
(assessed with the GCS) validity per language and outcome instrument.
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Table A1. Cont.































Note. * Reported SF-12v2 values used for the reliability analyses. ** Combined SF-12v2 values (i.e., reported
values and derived from the respective items of the SF-36v2) were used for the convergent and divergent validity
analyses; bold values represent samples with N ≥ 50.
Appendix B. Validity on Scale Level
Table A2. Convergent and discriminant validity of the PCL-5 scales.
Convergent Validity Discriminant Validity






Dutch −0.33 −0.46 −0.32 −0.45 −0.29 −0.15
English −0.24 −0.47 −0.24 −0.43 −0.18 −0.03
Finnish −0.38 −0.43 −0.33 −0.39 −0.27 −0.09
French −0.24 −0.43 −0.18 −0.44 −0.21 0.02
German −0.28 −0.61 −0.20 −0.47 0.02 0.26
Italian −0.30 −0.57 −0.27 −0.53 −0.24 0.13
Norwegian −0.33 −0.49 −0.29 −0.49 −0.27 −0.04
Spanish −0.25 −0.40 −0.24 −0.33 −0.28 0.03
Swedish −0.20 −0.27 −0.26 −0.19 −0.35 −0.13
Total
M −0.28 −0.46 −0.26 −0.41 −0.23 0.00
Max −0.20 −0.27 −0.18 −0.19 0.02 0.26
Min −0.38 −0.61 −0.33 −0.53 −0.35 −0.15
SD 0.06 0.10 0.05 0.10 0.11 0.13
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Convergent Validity Discriminant Validity
C
Dutch −0.26 −0.36 −0.23 −0.37 −0.23 −0.09
English −0.18 −0.38 −0.19 −0.34 −0.12 0.00
Finnish −0.27 −0.42 −0.26 −0.39 −0.28 −0.14
French −0.13 −0.45 −0.11 −0.39 −0.10 0.10
German −0.27 −0.48 −0.21 −0.42 −0.03 0.26
Italian −0.19 −0.48 −0.17 −0.46 −0.15 0.09
Norwegian −0.23 −0.38 −0.20 −0.38 −0.21 −0.03
Spanish −0.21 −0.29 −0.17 −0.28 −0.20 0.01
Swedish −0.26 −0.24 −0.26 −0.15 −0.26 −0.03






M −0.22 −0.39 −0.20 −0.35 −0.18 0.02
Max −0.13 −0.24 −0.11 −0.15 −0.03 0.26
Min −0.27 −0.48 −0.26 −0.46 −0.28 −0.14
SD 0.05 0.08 0.05 0.09 0.08 0.12
D
Dutch −0.33 −0.57 −0.31 −0.57 −0.41 −0.22
English −0.22 −0.67 −0.21 −0.62 −0.45 −0.19
Finnish −0.24 −0.59 −0.26 −0.57 −0.46 −0.18
French −0.20 −0.61 −0.15 −0.57 −0.29 −0.12
German −0.39 −0.60 −0.33 −0.56 −0.17 0.14
Italian −0.32 −0.68 −0.28 −0.65 −0.34 −0.01
Norwegian −0.39 −0.57 −0.34 −0.56 −0.41 −0.06
Spanish −0.29 −0.58 −0.30 −0.54 −0.49 −0.20
Swedish −0.25 −0.51 −0.29 −0.44 −0.45 −0.28
Total
M −0.29 −0.60 −0.27 −0.56 −0.39 −0.12
Max −0.20 −0.51 −0.15 −0.44 −0.17 0.14
Min −0.39 −0.68 −0.34 −0.65 −0.49 −0.28
SD 0.07 0.05 0.06 0.06 0.10 0.13
E
Dutch −0.37 −0.61 −0.34 −0.60 −0.43 −0.17
English −0.28 −0.67 −0.29 −0.64 −0.36 −0.09
Finnish −0.42 −0.61 −0.43 −0.55 −0.44 −0.20
French −0.25 −0.70 −0.21 −0.66 −0.35 −0.07
German −0.47 −0.60 −0.42 −0.60 −0.22 0.11
Italian −0.33 −0.69 −0.29 −0.65 −0.29 0.12
Norwegian −0.36 −0.64 −0.31 −0.63 −0.37 0.00
Spanish −0.32 −0.63 −0.33 −0.59 −0.36 −0.03
Swedish −0.20 −0.51 −0.30 −0.48 −0.42 −0.20
Total
M −0.33 −0.63 −0.32 −0.60 −0.36 −0.06
Max −0.20 −0.51 −0.21 −0.48 −0.22 0.12
Min −0.47 −0.70 −0.43 −0.66 −0.44 −0.20
SD 0.08 0.06 0.07 0.06 0.07 0.12
Note. Cluster B = Intrusion; Cluster C = Avoidance; Cluster D = Negative alterations in cognition and mood; Cluster E = Hyperarousal;
M = mean, Max = maximum, Min = minimum; SD = standard deviation; SF-36v2/SF-12v2—PCS = Physical Component Score; SF-36v2/SF-
12v2—MCS = Mental Component Score; GCS = Glasgow Coma Scale; GOSE = Glasgow Outcome Scale—Extended. Values in bold
represent an at least medium effect size (≥|0.30|), significant at α = 0.05.
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Table A3. Convergent and divergent validity of the QOLIBRI scales.
Convergent Validity Discriminant Validity






Dutch 0.40 0.58 0.38 0.57 0.43 0.21
English 0.34 0.61 0.37 0.58 0.43 0.20
Finnish 0.49 0.69 0.49 0.62 0.50 0.07
French 0.33 0.58 0.34 0.59 0.48 0.10
German 0.46 0.53 0.39 0.52 0.26 −0.05
Italian 0.44 0.61 0.46 0.58 0.40 0.02
Norwegian 0.42 0.54 0.41 0.52 0.34 −0.06
Spanish 0.41 0.52 0.43 0.49 0.33 0.07
Swedish 0.33 0.42 0.41 0.40 0.44 0.21
M 0.40 0.56 0.41 0.54 0.40 0.09
Max 0.49 0.69 0.49 0.62 0.50 0.21
Min 0.33 0.42 0.34 0.40 0.26 −0.06
SD 0.06 0.07 0.05 0.07 0.08 0.11
Self
Dutch 0.51 0.66 0.50 0.66 0.43 0.19
English 0.38 0.72 0.40 0.70 0.45 0.09
Finnish 0.50 0.78 0.52 0.69 0.50 0.04
French 0.49 0.73 0.42 0.71 0.46 0.07
German 0.49 0.70 0.41 0.71 0.29 −0.15
Italian 0.51 0.70 0.51 0.68 0.43 −0.07
Norwegian 0.45 0.68 0.43 0.65 0.35 −0.07
Spanish 0.57 0.61 0.61 0.59 0.46 0.13
Swedish 0.43 0.74 0.40 0.72 0.43 0.06
M 0.48 0.70 0.47 0.68 0.42 0.03
Max 0.57 0.78 0.61 0.72 0.50 0.19
Min 0.38 0.61 0.40 0.59 0.29 −0.15




Dutch 0.61 0.59 0.61 0.58 0.56 0.31
English 0.58 0.56 0.59 0.54 0.63 0.30
Finnish 0.63 0.65 0.61 0.58 0.55 0.14
French 0.62 0.69 0.58 0.66 0.59 0.18
German 0.63 0.58 0.55 0.58 0.41 0.06
Italian 0.64 0.65 0.64 0.61 0.62 0.15
Norwegian 0.50 0.64 0.49 0.62 0.48 0.05
Spanish 0.70 0.48 0.69 0.46 0.54 0.21
Swedish 0.62 0.58 0.64 0.54 0.66 0.39
M 0.61 0.60 0.60 0.57 0.56 0.20
Max 0.70 0.69 0.69 0.66 0.66 0.39
Min 0.50 0.48 0.49 0.46 0.41 0.05
SD 0.05 0.06 0.06 0.06 0.08 0.12
Social Rela-
tionships
Dutch 0.29 0.57 0.30 0.55 0.29 0.12
English 0.29 0.63 0.33 0.57 0.34 0.06
Finnish 0.34 0.71 0.37 0.59 0.33 0.10
French 0.35 0.61 0.32 0.58 0.33 0.01
German 0.36 0.56 0.31 0.51 0.11 −0.12
Italian 0.30 0.57 0.30 0.55 0.28 −0.15
Norwegian 0.23 0.50 0.21 0.48 0.15 −0.11
Spanish 0.34 0.52 0.35 0.51 0.31 0.11
Swedish 0.22 0.47 0.21 0.44 0.22 0.24
M 0.30 0.57 0.30 0.53 0.26 0.03
Max 0.36 0.71 0.37 0.59 0.34 0.24
Min 0.22 0.47 0.21 0.44 0.11 −0.15
SD 0.05 0.07 0.06 0.05 0.08 0.13
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Convergent Validity Discriminant Validity






Dutch 0.33 0.71 0.29 0.71 0.36 0.12
English 0.20 0.69 0.20 0.66 0.46 0.09
Finnish 0.31 0.70 0.30 0.65 0.39 0.11
French 0.26 0.71 0.19 0.68 0.29 0.00
German 0.28 0.64 0.23 0.63 0.09 −0.20
Italian 0.23 0.58 0.22 0.56 0.21 −0.10
Norwegian 0.34 0.73 0.27 0.72 0.30 −0.02
Spanish 0.26 0.44 0.24 0.43 0.28 0.04
Swedish 0.17 0.67 0.23 0.61 0.45 0.24
M 0.26 0.65 0.24 0.63 0.31 0.03
Max 0.34 0.73 0.30 0.72 0.46 0.24
Min 0.17 0.44 0.19 0.43 0.09 −0.20
SD 0.06 0.09 0.04 0.09 0.12 0.13
Physical
Dutch 0.70 0.48 0.66 0.47 0.53 0.14
English 0.64 0.44 0.65 0.45 0.57 0.28
Finnish 0.66 0.44 0.62 0.43 0.58 0.19
French 0.72 0.48 0.65 0.48 0.43 0.07
German 0.73 0.35 0.69 0.42 0.56 −0.04
Italian 0.56 0.55 0.55 0.54 0.47 0.04
Norwegian 0.70 0.54 0.67 0.52 0.57 0.14
Spanish 0.68 0.45 0.64 0.42 0.58 0.12
Swedish 0.67 0.26 0.67 0.19 0.61 0.36
M 0.67 0.44 0.64 0.44 0.54 0.15
Max 0.73 0.55 0.69 0.54 0.61 0.36
Min 0.56 0.26 0.55 0.19 0.43 −0.04
SD 0.05 0.09 0.04 0.10 0.06 0.12
Note. M = mean, Max = maximum, Min = minimum; SD = standard deviation; SF-36v2/SF-12v2—PCS = Physical Component Score;
SF-36v2/SF-12v2—MCS = Mental Component Score; GCS = Glasgow Coma Scale; GOSE = Glasgow Outcome Scale—Extended. Values in
bold represent an at least medium effect size (≥|0.30|), significant at α = 0.05.
Table A4. Convergent and divergent validity of the SF-36v2 scales.
Convergent Validity Discriminant Validity
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Table A4. Cont.
Convergent Validity Discriminant Validity
















Note. M = mean, Max = maximum, Min = minimum; SD = standard deviation; PF = Physical functioning; BP = Bodily Pain; GH = General
Health; VT = Vitality; SF = Social Functioning; RE = Role-Emotional; MH = Mental Health; PCS = Physical Component Score; MCS = Mental
Component Score; GCS = Glasgow Coma Scale; GOSE = Glasgow Outcome Scale—Extended. No correlations with the Reported Health
Transition (HT) scale reported because of the scale length (one item); values in bold represent an at least medium effect size (≥|0.30|),
significant at α = 0.05.
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